# Sarepta Therapeutics, Inc.: Form 8-K, filed Dec 13, 2019

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2019-12-13
- Accepted by EDGAR: Dec 13, 2019, 16:01 ET
- Period: 2019-12-12
- Accession: 0001564590-19-045957
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000156459019045957/srpt-8k_20191212.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000156459019045957/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000156459019045957/srpt-8k_20191212.htm

Filed Dec 13, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-045957. Last ingested by Listed: Nov 14, 2026, 19:58 ET. No prices; not investment advice.
